Abstract
Saikosaponin-A (SA), a class of native compound with numerous biological activities, may exert protective effect against postmenopausal bone loss. However, it remains unknown whether SA regulates the osteogenic differentiation of bone marrow stromal cells (BMSCs) in the treatment and prevention of osteoporosis. In this study, BMSCs were treated with various concentrations of SA to stimulate osteogenic differentiation over a 14-day period. Additionally, a canonical ovariectomized (OVX) mouse model was used to evaluate the effect of 3-month SA treatment in preventing postmenopausal osteoporosis. In vitro, we found that SA promotes alkaline phosphatase activity/staining and Alizarin red assay, stimulated the expression of osteogenic markers, i.e., runt-related transcription factor 2 (Runx2), osterix, osteopontin, and osteocalcin (OCN) in BMSCs. In vivo, the trabecular number, trabecular thickness, and trabecular bone mineral density of the distal femoral metaphysis were significantly increased in OVX mice treated intraperitoneally with SA for 3 months compared with OVX mice that not treated with SA. Moreover, the expression of Runx2 and OCN in OVX + SA mice was significantly increased than that in OVX mice. Finally, we found that SA activated the WNT/β-catenin pathway and the expression of several downstream genes including T-cell factor-1 and lymphoid enhancer factor-1. Inhibition of WNT/β-catenin pathway by Dickkopf-related protein 1 blocked the positive role of SA on osteogenesis. Therefore, SA promoted the osteogenic differentiation of BMSCs through WNT/β-catenin signaling.
Similar content being viewed by others
References
Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y, Li M, Zhang H, Xue X, Hou Z, Zhou Y, Yu Z, He G, Luo X (2016) Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through β-catenin. Stem Cell Rep 6:633
Li SF, Tang JJ, Chen J, Zhang P, Wang T, Chen TY, Yan B, Huang B, Wang L, Huang MJ, Zhang ZM, Jin DD (2015) Regulation of bone formation by baicalein via the mTORC1 pathway. Drug Des Dev Ther 9:5169–5183
Wang D, Ma W, Wang F, Dong J, Wang D, Sun B, Wang B (2015) Stimulation of Wnt/β-catenin signaling to improve bone development by naringin via interacting with AMPK and Akt. Cell Physiol Biochem 36:1563–1576
Li M, Wu W, Tan L, Mu D, Zhu D, Wang J, Zhao B (2015) Low-magnitude mechanical vibration regulates expression of osteogenic proteins in ovariectomized rats. Biochem Biophys Res Commun 465:344–348
Curtis JR, Cai Q, Wade SW, Stolshek BS, Adams JL, Balasubramanian A, Viswanathan HN, Kallich JD (2013) Osteoporosis medication adherence: physician perceptions vs. patients’ utilization. Bone 55:1–6
Tao X, Qi Y, Xu L, Yin L, Han X, Xu Y, Wang C, Sun H, Peng J (2016) Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis. Pharmacol Res 108:90–101
Lewiecki EM (2011) New targets for intervention in the treatment of postmenopausal osteoporosis. Nat Rev Rheumatol 7:631–638
Mulder JE, Kolatkar NS, LeBoff MS (2006) Drug insight: existing and emerging therapies for osteoporosis. Nat Clin Pract Endocrinol Metab 2:670–680
Chen JS, Sambrook PN (2012) Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol 8:81–91
Zhou C, Liu W, He W, Wang H, Chen Q, Song H (2015) Saikosaponin a inhibits RANKL-induced osteoclastogenesis by suppressing NF-kappaB and MAPK pathways. Int Immunopharmacol 25:49–54
Shin JE, Kim HJ, Kim KR, Lee SK, Park J, Kim H, Park KK, Chung WY (2015) Type I saikosaponins a and d inhibit osteoclastogenesis in bone marrow-derived macrophages and osteolytic activity of metastatic breast cancer cells. Evid Based Complement Alternat Med 2015:582437
Ye M, Bi YF, Ding L, Zhu WW, Gao W (2016) Saikosaponin a functions as anti-epileptic effect in pentylenetetrazol induced rats through inhibiting mTOR signaling pathway. Biomed Pharmacother 81:281–287
Chen E, Chen J, Cao SL, Zhang QZ, Jiang XG (2010) Preparation of nasal temperature-sensitive in situ gel of Radix Bupleuri and evaluation of the febrile response mechanism. Drug Dev Ind Pharm 36:490–496
Bermejo P, Abad MJ, Diaz AM, Fernandez L, De Santos J, Sanchez S, Villaescusa L, Carrasco L, Irurzun A (2002) Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia. Planta Med 68:106–110
Sun Y, Cai TT, Zhou XB, Xu Q (2009) Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis. Int Immunopharmacol 9:978–983
Ma Y, Bao Y, Wang S, Li T, Chang X, Yang G, Meng X (2016) Anti-inflammation effects and potential mechanism of saikosaponins by regulating nicotinate and nicotinamide metabolism and arachidonic acid metabolism. Inflammation 39:1453–1461
Fu Y, Hu X, Cao Y, Zhang Z, Zhang N (2015) Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in Human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts. Free Radic Biol Med 89:777–785
Yu YH, Xie W, Bao Y, Li HM, Hu SJ, Xing JL (2012) Saikosaponin a mediates the anticonvulsant properties in the HNC models of AE and SE by inhibiting NMDA receptor current and persistent sodium current. PLoS One 7:e50694
Liu YQ, Hong ZL, Zhan LB, Chu HY, Zhang XZ, Li GH (2016) Wedelolactone enhances osteoblastogenesis by regulating Wnt/beta-catenin signaling pathway but suppresses osteoclastogenesis by NF-kappaB/c-fos/NFATc1 pathway. Sci Rep 6:32260
Du L, Nong MN, Zhao JM, Peng XM, Zong SH, Zeng GF (2016) Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/β-catenin signalling pathway. Sci Rep 6:32261
Su X, Liao L, Shuai Y, Jing H, Liu S, Zhou H, Liu Y, Jin Y (2015) MiR-26a functions oppositely in osteogenic differentiation of BMSCs and ADSCs depending on distinct activation and roles of Wnt and BMP signaling pathway. Cell Death Dis 6:e1851
Jackson WM, Nesti LJ, Tuan RS (2012) Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med 1:44–50
Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739–2749
Ma ZP, Liao JC, Zhao C, Cai DZ (2015) Effects of the 1, 4-dihydropyridine L-type calcium channel blocker benidipine on bone marrow stromal cells. Cell Tissue Res 361:467–476
Yao W, Guan M, Jia J, Dai W, Lay YA, Amugongo S, Liu R, Olivos D, Saunders M, Lam KS, Nolta J, Olvera D, Ritchie RO, Lane NE (2013) Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells 31:2003–2014
Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE (2012) Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 18:456–462
Jiang J, Li J, Jia X (2014) The antiosteoporotic activity of central-icaritin (CIT) on bone metabolism of ovariectomized rats. Molecules 19:18690–18704
Sun W, Wang YQ, Yan Q, Lu R, Shi B (2014) Effects of Er-Zhi-Wan on microarchitecture and regulation of Wnt/beta-catenin signaling pathway in alveolar bone of ovariectomized rats. J Huazhong Univ Sci Technolog Med Sci 34:114–119
He G, Guo W, Lou Z, Zhang H (2014) Achyranthes bidentata saponins promote osteogenic differentiation of bone marrow stromal cells through the ERK MAPK signaling pathway. Cell Biochem Biophys 70:467–473
Wang Y, Huang X, Tang Y, Lin H, Zhou N (2016) Effects of panax notoginseng saponins on the osteogenic differentiation of rabbit bone mesenchymal stem cells through TGF-β1 signaling pathway. BMC Complement Altern Med 16:319
Schilling T, Ebert R, Raaijmakers N, Schutze N, Jakob F (2014) Effects of phytoestrogens and other plant-derived compounds on mesenchymal stem cells, bone maintenance and regeneration. J Steroid Biochem Mol Biol 139:252–261
Siddiqi MH, Siddiqi MZ, Ahn S, Kim YJ, Yang DC (2014) Ginsenoside Rh1 induces mouse osteoblast growth and differentiation through the bone morphogenetic protein 2/runt-related gene 2 signalling pathway. J Pharm Pharmacol 66:1763–1773
Niu Y, Li Y, Huang H, Kong X, Zhang R, Liu L, Sun Y, Wang T, Mei Q (2011) Asperosaponin VI, a saponin component from Dipsacus asper wall, induces osteoblast differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway. Phytother Res 25:1700–1706
Huang Q, Gao B, Wang L, Zhang HY, Li XJ, Shi J, Wang Z, Zhang JK, Yang L, Luo ZJ, Liu J (2015) Ophiopogonin D: a new herbal agent against osteoporosis. Bone 74:18–28
Wang L, Zhang YG, Wang XM, Ma LF, Zhang YM (2015) Naringin protects human adipose-derived mesenchymal stem cells against hydrogen peroxide-induced inhibition of osteogenic differentiation. Chem Biol Interact 242:255–261
Serigano K, Sakai D, Hiyama A, Tamura F, Tanaka M, Mochida J (2010) Effect of cell number on mesenchymal stem cell transplantation in a canine disc degeneration model. J Orthop Res 28:1267–1275
Ying X, Chen X, Feng Y, Xu HZ, Chen H, Yu K, Cheng S, Peng L (2014) Myricetin enhances osteogenic differentiation through the activation of canonical Wnt/β-catenin signaling in human bone marrow stromal cells. Eur J Pharmacol 738:22–30
Tao K, Xiao D, Weng J, Xiong A, Kang B, Zeng H (2016) Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway. Toxicol Lett 240:68–80
Xiao JJ, Zhao WJ, Zhang XT, Zhao WL, Wang XX, Yin SH, Jiang F, Zhao YX, Chen FN, Li SL (2015) Bergapten promotes bone marrow stromal cell differentiation into osteoblasts in vitro and in vivo. Mol Cell Biochem 409:113–122
Marie PJ, Kassem M (2011) Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Eur J Endocrinol 165:1–10
Ai M, Holmen SL, Van Hul W, Williams BO, Warman ML (2005) Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol Cell Biol 25:4946–4955
Acknowledgements
We thank Cong Luo (Southern Medical University, PR China) for excellent technical support with micro-CT.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Weiqi Huang, Xiaoling Zheng, Xiaodong Yang, and Shicai Fan state that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This study was ethically approved by the Institutional Animal Care and Use Committee of Southern Medical University and performed in accordance with the criteria defined by the rules of the committee.
Rights and permissions
About this article
Cite this article
Huang, W., Zheng, X., Yang, X. et al. Stimulation of Osteogenic Differentiation by Saikosaponin-A in Bone Marrow Stromal Cells Via WNT/β-Catenin Pathway. Calcif Tissue Int 100, 392–401 (2017). https://doi.org/10.1007/s00223-017-0242-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-017-0242-y